Previous article
RSV Vaccination During Pregnancy Improves Infant Outcomes
Sep 2025
Next article
Unilateral Knee Swelling
Cochrane for Clinicians

Galantamine for Dementia due to Alzheimer Disease and Mild Cognitive Impairment

Juan Qiu, MD, PhD,
Dongsheng Jiang, MD,
Penn State University College of Medicine, State College

American Family Physician. 2025;112(3):258-259.

Author disclosure: No relevant financial relationships.

This clinical content conforms to AAFP criteria for CME.

Author disclosure: No relevant financial relationships.

  1. 1.Lim AWY, Schneider L, Loy C. Galantamine for dementia due to Alzheimer's disease and mild cognitive impairment. Cochrane Database Syst Rev. 2024(11):CD001747.
  2. 2.Alzheimer's Association. 2024 Alzheimer's disease facts and figures. Accessed July 1, 2024. https://www.alz.org/media/Documents/alzheimers-facts-and-figures.pdf
  3. 3.Hyde C, Peters J, Bond M, et al. Evolution of the evidence on the effectiveness and cost-effectiveness of acetylcholinesterase inhibitors and memantine for Alzheimer's disease: systematic review and economic model. Age Ageing. 2013;42(1):14-20.
  4. 4.McShane R, Areosa Sastre A, Minakaran N. Memantine for dementia. Cochrane Database Syst Rev. 2006(2):CD003154.
  5. 5.Schmidt R, Hofer E, Bouwman FH, et al. EFNS-ENS/EAN guideline on concomitant use of cholinesterase inhibitors and memantine in moderate to severe Alzheimer's disease. Eur J Neurol. 2015;22(6):889-898.

These are summaries of reviews from the Cochrane Library.

This series is coordinated by Corey D. Fogleman, MD, assistant medical editor.

A collection of Cochrane for Clinicians published in AFP is available at https://www.aafp.org/afp/cochrane.

Previous article
RSV Vaccination During Pregnancy Improves Infant Outcomes
Sep 2025
Next article
Unilateral Knee Swelling

Current issue

May 2026

May 2026

Copyright © 2026 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. See permissions for copyright questions and/or permission requests.